TEGLIN

About

Teglin is an oral antidiabetic medication belonging to the dipeptidyl peptidase-4 (DPP-4) inhibitor class. It works by increasing the levels of incretin hormones, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which are naturally released throughout the day and in response to meals. These hormones play a crucial role in glucose homeostasis by stimulating insulin secretion from pancreatic beta cells and suppressing glucagon secretion from alpha cells in a glucose-dependent manner. This mechanism helps to lower both fasting and post-meal blood glucose levels without significantly increasing the risk of hypoglycemia when used as monotherapy. Teglin is typically used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Its action is glucose-dependent, meaning it primarily works when blood glucose levels are elevated, offering a favorable safety profile.

Uses

• Management of type 2 diabetes mellitus.
• Improvement of glycemic control in adults.
• Used as an adjunct to diet and exercise.
• Monotherapy or in combination with other antidiabetic agents.

Directions For Use

Take Teglin orally once daily, with or without food, as directed by your physician. Do not crush or chew the tablet.

Benefits

• Effectively lowers blood glucose levels.
• Low risk of hypoglycemia when used alone.
• Can be taken once daily for convenience.
• Improves both fasting and post-meal glucose.
• Generally well-tolerated.
• Does not typically cause weight gain.

Side Effects

• Headache
• Nasal congestion
• Sore throat
• Upper respiratory tract infection
• Diarrhea
• Nausea
• Abdominal pain
• Joint pain
• Pancreatitis (rare but serious)
• Allergic reactions (rash, hives)
• Kidney problems (rare)
• Skin reactions (bullous pemphigoid)

Safety Measures

• Alcohol - Moderate alcohol consumption is generally acceptable, but excessive intake may affect blood sugar levels and should be discussed with a doctor.
• Pregnancy - Use during pregnancy is generally not recommended unless clearly necessary, as data on human pregnancy are limited. Consult your doctor.
• Breastfeeding - It is unknown if Teglin is excreted in human milk. A decision should be made whether to discontinue nursing or the drug, considering the importance of the drug to the mother.
• Liver - Use with caution in patients with mild to moderate hepatic impairment. Dose adjustment may be required in severe cases.
• Kidney - Dose adjustment may be necessary in patients with moderate to severe renal impairment or end-stage renal disease.
• Lung - No specific precautions are generally required for patients with pre-existing lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.